A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) today announced the ...

Cancer treatments can exert cardiotoxic effects, but screening and monitoring can detect and minimize cancer therapy-related ...

The first meta-analysis analyzed 70,361 participants from 10 randomized trials, and found those allocated to receive an SGLT2 ...

Empagliflozin therapy was associated with improved kidney outcomes regardless of diabetes, HF, cause of kidney disease, or severity of kidney disease.

Unlike the general population, patients on maintenance hemodialysis have both traditional and nontraditional risk factors that put them at high cardiovascular risk, despite use of standard lipid and ...

Pharmacological inhibition of the renin-angiotensin system in the whole spectrum of patients with heart failure with reduced ejection fraction: data based on the heart failure obs ...

Yesterday, October 29, the world was united in the emotional campaign for World Stroke Day with the theme ldquo;Every Minute ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel therapies to manage inflammation, lipids, hypertension, obesity, diabetes and ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The path forward to prioritizing women’s health and well-being must be laid by Canadians whose voices propel political, social and economic change around the world.